Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (24594)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 27, 2020 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chung W, Promrat K, Wands J. Clinical implications, diagnosis, and management of diabetes in patients with chronic liver diseases. World J Hepatol 2020; 12(9): 533-557 [PMID: 33033564 DOI: 10.4254/wjh.v12.i9.533] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v12/i9/533.htm |
| Number | Citing Articles |
| 1 |
Zahra Tolou-Ghamari, Abbas-Ali Palizban. Biomarkers, Biocatalysts, or Pathology Conditions to Evaluate Potential History of Liver Disease such as Cancer. Clinical Cancer Investigation Journal 2022; 11(6): 31 doi: 10.51847/caGjAHyB9E
|
| 2 |
Ahmed Abdallah Salman, Mohamed Abdalla Salman, Mostafa Said, Hesham Elkassar, Mohammad El Sherbiny, Ahmed Youssef, Mohammed Elbaz, Ahmed M. Elmeligui, Mohamed Badr Hassan, Mahmoud Gouda Omar, Hussien Samir, Mohamed Abdelkader Morad, Hossam El-Din Shaaban, Mohamed Youssef, Ahmed Moustafa, Mohamed Sabry Tourky, Ahmed Elewa, Sadaf Khalid, Khaled Monazea, Mohamed Shawkat. Albuminuria as a predictor of mortality in type II diabetic patients after living-donor liver transplantation. Annals of Medicine 2022; 54(1): 2597 doi: 10.1080/07853890.2022.2124446
|
| 3 |
Zeynep Melekoglu Ellik. Current Perspective on Diabetes Mellitus in Clinical Sciences. 2023; : 399 doi: 10.69860/nobel.9786053359111.37
|
| 4 |
Layla A. Alahmari, Lashin S. Ali, Hoda A. Fansa, Dalal S. Alshaya, Fawziah A. Al‐Salmi, Ehab I. El‐Hallous, Mamdouh Eldesoqui, Fahmy Gad Elsaid, Eman Fayad, Ahmed A. El‐Mansy, Ghadi Alsharif, Dlovan Y. Khalil, Maryam Bakir Mahmood, Rozhan Yassin Khalil, Hanan M. Rashwan, Shady G. El‐Sawah. Antioxidant and Antiapoptotic Effects of Selenium And Nano Selenium‐Loaded Exosomes on Hepatic Dysfunction of Type 1 Diabetic Rats. Journal of Experimental Zoology Part A: Ecological and Integrative Physiology 2024; doi: 10.1002/jez.2881
|
| 5 |
Si Ho Kim, Eun Ju Cho, Boo‐ok Jang, Kyunghan Lee, Jae Kyun Choi, Gwang Hyeon Choi, Jeong‐Hoon Lee, Su Jong Yu, Yoon Jun Kim, Yun Bin Lee, Jeong‐Hwan Yoon, Jin‐Wook Kim, Sook‐Hyang Jeong, Eun Sun Jang. Comparison of biochemical response during antiviral treatment in patients with chronic hepatitis B infection. Liver International 2022; 42(2): 320 doi: 10.1111/liv.15086
|
| 6 |
Alessandro Mantovani, Giovanni Targher, Christopher D. Byrne. Textbook of Diabetes. 2024; : 820 doi: 10.1002/9781119697473.ch57
|
| 7 |
Maria Corina Plaz Torres, Ariel Jaffe, Rachel Perry, Elisa Marabotto, Mario Strazzabosco, Edoardo G. Giannini. Diabetes medications and risk of HCC. Hepatology 2022; 76(6): 1880 doi: 10.1002/hep.32439
|
| 8 |
Ji-Xian Song, Ji-Ren An, Qi Chen, Xin-Yue Yang, Cui-Ling Jia, Shan Xu, Ya-shuo Zhao, En-Sheng Ji. Liraglutide attenuates hepatic iron levels and ferroptosis in db/db mice. Bioengineered 2022; 13(4): 8334 doi: 10.1080/21655979.2022.2051858
|
| 9 |
Ashok Choudhury, Ruveena Rajaram, Shiv Kumar Sarin. Acute-on-chronic liver failure in metabolic dysfunction-associated fatty liver disease patients: a disease multiplier. Hepatology International 2024; 18(S2): 941 doi: 10.1007/s12072-024-10711-4
|
| 10 |
Zeinab Seif El-Din, Mohammed Afify, Essam Zayed, Dalia Elsabaawy, El Sayed Tharwa, Ahmed Elsharawy, Eman Abdelsameea, Mohamed Akl Rady. Dapagliflozin as an oral antihyperglycemic agent in the management of diabetes mellitus in patients with liver cirrhosis. World Journal of Experimental Medicine 2024; 14(4): 95272 doi: 10.5493/wjem.v14.i4.95272
|
| 11 |
Chuxin Huang, Jiali Qian, Ying Liu, Li Zhang, Yehong Yang. Empagliflozin attenuates liver fibrosis in high‐fat diet/streptozotocin‐induced mice by modulating gut microbiota. Clinical and Experimental Pharmacology and Physiology 2024; 51(3) doi: 10.1111/1440-1681.13842
|
| 12 |
Eman Yousef Moursi, Pacint Elsayed Moez, Ehab Mostafa Hassouna, Eman Zakareya Elkemary, Geilan Mahmoud Marei, Mohammed Said Sayed Shater, Mai Hesham Mohammed Badrah. MALAT1 and MEG3 genes expression in non-alcoholic fatty liver disease in type 2 diabetes mellitus patients: a case-control study. Alexandria Journal of Medicine 2023; 59(1): 86 doi: 10.1080/20905068.2023.2251221
|
| 13 |
Marcio José Concepción-Zavaleta, José Paz-Ibarra, Alejandro Román-González, Luis Alberto Concepción-Urteaga, María Alejandra Quispe-Flores, Jhean Gabriel Gonzáles-Yovera, Luciana del Pilar Rafael-Robles, María del Carmen Durand-Vásquez, Elman Rolando Gamarra-Osorio, Juan Eduardo Quiroz-Aldave. From liver to hormones: The endocrine consequences of cirrhosis. World Journal of Gastroenterology 2024; 30(9): 1073-1095 doi: 10.3748/wjg.v30.i9.1073
|
| 14 |
Laurent Castera, Kenneth Cusi. Diabetes and cirrhosis: Current concepts on diagnosis and management. Hepatology 2023; 77(6): 2128 doi: 10.1097/HEP.0000000000000263
|
| 15 |
Pankaj Puri, Narendra Kotwal. An Approach to the Management of Diabetes Mellitus in Cirrhosis: A Primer for the Hepatologist. Journal of Clinical and Experimental Hepatology 2022; 12(2): 560 doi: 10.1016/j.jceh.2021.09.010
|
| 16 |
Ji Cheol Bae, Lauren A. Beste, Kristina M. Utzschneider. The Impact of Insulin Resistance on Hepatic Fibrosis among United States Adults with Non-Alcoholic Fatty Liver Disease: NHANES 2017 to 2018. Endocrinology and Metabolism 2022; 37(3): 455 doi: 10.3803/EnM.2022.1434
|